Adagene Inc.
Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer. They drive a precision immunotherapy platform through multiple modalities and have global partnerships and collaborations with a network of international organizations. Leading assets include ADG106, ADG116, and ADG126. The company is driven by a powerful platform combining computational biology and artificial intelligence to create novel antibodies.
Offisielt Register
AI Kvalitetsanalyse
Tillitsscore Detaljer
Snarveier
Nettside Høydepunkter
🌟 Lignende Pålitelige Bedrifter
Metagenomi, Inc.
Metagenomi is an in vivo genome editing company creating curative genetic medicines using proprietary technologies. They leverage metagenomics to discover editing tools potentially capable of correcting any type of genetic mutation. The company focuses on diseases with well-understood biology and clear regulatory pathways, and intends to expand their pipeline through genetic editing capabilities.
ARCTICZYMES TECHNOLOGIES ASA
ArcticZymes Technologies er et bioteknologiselskap som spesialiserer seg på utvikling og produksjon av enzymer. De tilbyr nukleaser for bioframstilling og molekylær diagnostikk, inkludert Saltaktive nukleaser (SAN). Selskapet er kjent for sine polymeraser og enzymer brukt i forskning og industrielle anvendelser.
ACD PHARMACEUTICALS AS
ACD Pharma is a Norwegian R&D company developing biocontrol products based on bacteriophages, focusing on combating harmful bacteria in animals and humans. They launched Custus®YRS, the world's first bacteriophage product for aquaculture. They collaborate with pharmaceutical and scientific teams to fight antibiotic resistance, extending their advancements across sectors.